Viking Global Investors LP

Viking Global Investors LP is listed in filings as 10% Owner at Inhibrx Biosciences, Inc.. This profile follows SEC Form 4 activity through Oct 9, 2025, including sale activity. Recent filings connect the profile to Inhibrx Biosciences, Inc. (INBX) and BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Jul 1, 2025 to Oct 9, 2025. Reported amounts are shown as $526.2K to $10.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.